Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes
NCT: NCT07704320 · RECRUITING
Brief Summary
A team of researchers at Rice University in partnership with clinicians at Queen Elizabeth Central Hospital created BreathAlert, a low cost battery-powered monitor that detects and corrects apnea. This study evaluates the ability of BreathAlert to detect respiration and apneic episodes in infants. Data from BreathAlert and vital signs monitors is collected. The performance of BreathAlert in respiration and apnea detection is compared with traditional vital sign monitoring which may include temperature, heart rate, EKG, respiratory rate, SPO2 and impedance pneumography.
Frequently Asked Questions
What is Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes?
Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes is a clinical trial registered under NCT07704320. Current status: RECRUITING.
What is the status of NCT07704320?
The current status of NCT07704320 (Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes) is: RECRUITING.
When did Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes start?
Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes started on 2017-03-11.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.